It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2021.
2021 | Hyderabad, Telangana, India | ActiveSereno Life Sciences Private Limited, a active private limited company, was established on 13 January 2021 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24110TG2021PTC147686. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
Its leadership includes Manohar Aribandi (Director), Venkateswara Rao Atluri (Director), Bobba Raghavendra Rao (Director). Past directors included Ponduru Arun Prasad. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Villa No.09, 13Th Phase Indurfortune Fields, Kukatpally, Hyderabad, Telangana, 500072.
U24110TG2021PTC147686
147686
13 January 2021
₹1.00 M
₹0.10 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Sereno Life Sciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manohar Aribandi | Director | 15 Oct 2021 | Current |
| Venkateswara Rao Atluri | Director | 01 Nov 2021 | Current |
| Bobba Raghavendra Rao | Director | 11 Oct 2023 | Current |
| Sivannarayana Chunduri | Director | 01 Nov 2021 | Current |
| Manaswini Vemulapalli | Director | 13 Jan 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 11 Oct 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Sereno Life Sciences's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Sereno Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Sereno Life Sciences has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Sereno Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sereno Life Sciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Sereno Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Sereno Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.
Bobba Raghavendra Rao was appointed as a Director was appointed as a Director on 11 Oct 2023 & has been associated with this company since 2 years 1 month . was recorded as a recent event.
The activity Venkateswara Rao Atluri was appointed as a Director was appointed as a Director on 01 Nov 2021 & has been associated with this company since 4 years 29 days . was completed.
Progress on Sivannarayana Chunduri was appointed as a Director was appointed as a Director on 01 Nov 2021 & has been associated with this company since 4 years 29 days . was documented.
Progress on Manohar Aribandi was appointed as a Director was appointed as a Director on 15 Oct 2021 & has been associated with this company since 4 years 1 month . was documented.
The CIN of Sereno Life Sciences Private Limited is U24110TG2021PTC147686.
Sereno Life Sciences Private Limited is headquartered at Villa No.09, 13Th Phase Indurfortune Fields, Kukatpally, Hyderabad, Telangana, 500072.
Sereno Life Sciences Private Limited was incorporated on 13 January 2021.
The current directors of Sereno Life Sciences Private Limited are
The primary industry of Sereno Life Sciences Private Limited is Pharma.
Sereno Life Sciences Private Limited is unlisted.
The authorized capital of Sereno Life Sciences Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX